Discontinued — last reported Q1 '18
North America Generics — Goodwill, Impaired, Accumulated Impairment Loss
Analysis
How to read this metric
An increase indicates that the company has determined the North American generics business is worth less than previously recorded, signaling potential past overpayment for acquisitions or deteriorating competitive positioning in that market. A stable or non-increasing value suggests that the segment's performance remains consistent with the original valuation assumptions made during acquisition.
Detailed definition
This metric represents the cumulative historical impairment charges recognized against goodwill specifically allocated t...
Peer comparison
Peers in the pharmaceutical and generic drug industry often report similar goodwill impairment charges following large-scale M&A activity, with investors comparing these figures to assess the success of past capital allocation and acquisition strategies.
vtrs_segment_north_america_generics_goodwill_impaired_accumulated_impairment_lossSimilar Metrics at Other Companies
Frequently Asked Questions
- What does north america generics — goodwill, impaired, accumulated impairment loss mean?
- The total amount of value written off from goodwill associated with the North American generics business segment due to impairment.